Targeted therapy of liver fibrosis/cirrhosis and its complications

Journal of Hepatology

Volumn 55, Issue 3, 2011, Pages 726-728

  Poelstra, Klaas ^a   Schuppan, Detlef ^b,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antifibrotic therapy; Cholangiocyte; Drug; Fibrosis; HCC; Hepatocyte; Kupffer cell; Liver; Macrophage; Myofibroblast; Stellate cell; Targeting

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANTIBODY; DOXORUBICIN; DRUG CARRIER; GLIOTOXIN; GLYCYRRHETINIC ACID DERIVATIVE; IMATINIB; INTERLEUKIN 10; LIPOSOME; LOSARTAN; MYCOPHENOLIC ACID; PENTOXIFYLLINE; PROSTAGLANDIN DERIVATIVE;

ARTICLE; CELL SPECIFICITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MYOFIBROBLAST; PRIORITY JOURNAL; STELLATE CELL; VIRUS;

EID: 84860389169     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.04.008     Document Type: Note

References (0)